600 mg per day. Livhealth-365™ has been trialed as a single 600 mg dose once per day, and separately in divided doses of 300 mg twice per day. Both human clinical studies supported Livhealth-365™ in its promotion of healthier liver fat levels.

In both clinical studies, LivHealth365 was administered with food.

Livhealth-365™ utilizes the juice extract and albedo (pulp) fibers of the bergamot citrus fruit, prepared by patented specifications with and extract artichoke (Cynara cardunculus) leaves.

Yes, Livhealth-365™ is patented for composition, manufacturing process and application in the therapeutic support of healthy liver fat levels.

Yes, Livhealth-365™ is standardized by process to consistently result in no less than 17% bergamot polyphenols (inclusive of neo-hesperidin, naringin, bruteridin, melitidin and neo-eriocitrin) and 5% cynaropicrin from artichoke leaf.

No, Livhealth-365™ is a completely solvent-free dietary supplement.

The active group lost 9.6 lbs, whereas the placebo group only lost 5.2 lbs. over the 12-week study.

No. The novel use of bergamot pulp fibers helps the material maintain a free flow during production and does not oblige the use of excipients.

Livhealth-365™ undergoes a patented production process that includes the addition of bergamot albedo (pulp) fibers, and further consists of a method of co-grinding and micronization. A clinical study evidenced that the method of preparation activated synergistic value that is not available in the standalone extracts of either ingredient.

It has been found that the albedo (pulp) fibers enhance the bioavailability of both bergamot and cynara polyphenols on an average of 2.5X.

In both studies there was an average of 2x the reduction of liver fat, over the placebo groups.

In the 16-week study of Livhealth-365™'s patented active on fatty liver and vascular changes in Diabetic subjects, the Reactive Hyperemia Index (RHI) increased. Reactive Hyperemia Index is a measure of endothelial function and has been viewed as a predictive of cardiovascular events. An increase suggests improved free flow of blood and thus supportive of vascular health.

Yes, Livhealth-365™ has been subjected to 28-day and 90-day repeat-dose, toxicity studies and found not to exhibit any safety concerns or changes.